4.6 Article

Antigen-Specific Transfer of Functional Programmed Death Ligand 1 from Human APCs onto CD8+ T Cells via Trogocytosis

Journal

JOURNAL OF IMMUNOLOGY
Volume 188, Issue 2, Pages 744-752

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1101412

Keywords

-

Categories

Funding

  1. Deutsche Forschungsgemeinschaft [SFB643, MA 1351/8-1]
  2. Bavarian Immunotherapy Network (BayImmuNet)

Ask authors/readers for more resources

Upon specific interaction with APCs, T cells capture membrane fragments and surface molecules in a process termed trogocytosis. In this study, we demonstrate that human Ag-specific CD8(+) T cells acquire the coinhibitory molecule programmed death ligand 1 (PD-L1) from mature dendritic cells (mDC) and tumor cells in an Ag-specific manner. Immature dendritic cells were less effective in transferring surface molecules onto CD8(+) T cells than mDCs. Interestingly, trogocytosis of PD-L1 requires cell-cell contact and cannot be induced by uptake of soluble proteins obtained from mDC lysates. The transfer process is impaired by inhibition of vacuolar ATPases in T cells as well as by fixation of dendritic cells. Of importance, CD8(+) T cells that acquired PD-L1 complexes were able to induce apoptosis of neighboring programmed death 1-expressing CD8(+) T cells. In summary, our data demonstrate that human CD8(+) T cells take up functionally active PD-L1 from APCs in an Ag-specific fashion, leading to fratricide of programmed death 1-expressing, neighboring T cells. The transfer of functionally active coinhibitory molecules from APCs onto human CD8(+) T cells could have a regulatory role in immune responses. The Journal of Immunology, 2012, 188: 744-752.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma

Margarete M. Karg, Lukas John, Nasrin Refaian, Christian Buettner, Tanja Rottmar, Jonas Sommer, Barbara Bock, Yazid J. Resheq, Bruce R. Ksander, Ludwig M. Heindl, Andreas Mackensen, Jacobus J. Bosch

Summary: This study identifies midkine as a survival factor that drives liver metastasis and therapeutic resistance in uveal melanoma.

MOLECULAR CANCER RESEARCH (2022)

Article Hematology

Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9high AML cell subset

Martin Boettcher, Konstantinos Panagiotidis, Heiko Bruns, Martina Stumpf, Simon Voelkl, Stefanie Geyh, Barbara Dietel, Thomas Schroeder, Andreas Mackensen, Dimitrios Mougiakakos

Summary: BM stroma acts as a protective niche for AML cells, and upregulation of S100A8/A9 after stromal contact increases therapeutic resistance in AML cells.

BLOOD ADVANCES (2022)

Article Multidisciplinary Sciences

The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome

Silja Richter, Martin Boettcher, Simon Voelkl, Andreas Mackensen, Evelyn Ullrich, Benedikt Jacobs, Dimitrios Mougiakakos

Summary: This study found that reconstituting immune cells undergo metabolic changes after autologous stem cell transplantation, including increased proliferative activity and upregulation of glycolytic and fatty acid oxidation machinery. This metabolic activation is more pronounced in T-cells of advanced differentiation stages, CD56(bright) NK cells, and CD14(++)CD16(+) intermediate monocytes. Furthermore, persistent metabolic activation is associated with poor disease course in lymphoma patients within the first year following transplantation.

SCIENTIFIC REPORTS (2022)

Article Pharmacology & Pharmacy

Students' guide to documentation in clinical trials

Johannes Heck, Ann-Kathrin Rath, Katrin Wons, Carsten Schumacher, Anna Kutschenko, Nina Noltemeyer, Sarana Ulaganathan, Luca J. Vossiek, Hemme Hijma, Jeroen van Smeden, Christoph Schroeder, Dirk O. Stichtenoth, Heiner Wedemeyer, Christoph Schindler, Jacobus J. Bosch

Summary: In the midst of the COVID-19 pandemic, support from students in clinical trials for documentation has become crucial. Facing challenges in training due to social-distancing regulations, a panel of experts from Germany and the Netherlands developed a Students' guide to documentation in clinical trials to provide necessary training materials and define quality standards.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Review Oncology

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

Igor Radanovic, Naomi Klarenbeek, Robert Rissmann, Geert Jan Groeneveld, Emilie M. J. van Brummelen, Matthijs Moerland, Jacobus J. Bosch

Summary: This study investigated the utilization of immuno-oncology compounds in clinical trials with healthy volunteers and the evaluation of pharmacodynamic endpoints. The study found that while these trials are not widely conducted, they offer advantages such as early dose selection and prevention of non-therapeutic dosing regimens for cancer patients. The focus is on safety and pharmacodynamic endpoints.

FRONTIERS IN ONCOLOGY (2022)

Letter Hematology

Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy

Hannah Reimann, Anita N. Kremer, Viktoria Blumenberg, Katja Schmidt, Michael Aigner, Benedikt Jacobs, Nina Eisenhauer, Alina Kaempf, Wolf Roesler, Soraya Kharboutli, Dimitrios Mougiakakos, Vanessa Lang, Christopher Lischer, Pascal Irrgang, Moritz Leppkes, Julio Vera Gonzalez, Gerhard Kroenke, Andreas E. Kremer, Matthias Tenbusch, Heiko Bruns, Thomas Harrer, Fabian Mueller, Georg Schett, Andreas Mackensen, Marion Subklewe, Simon Voelkl

BLOOD ADVANCES (2023)

Review Oncology

Role of CAR T Cell Metabolism for Therapeutic Efficacy

Judit Rial Saborido, Simon Voelkl, Michael Aigner, Andreas Mackensen, Dimitrios Mougiakakos

Summary: CAR T cell therapy has revolutionized cancer treatment, but exhaustion and metabolic dysfunction of CAR T cells hinder their efficacy. Tumor cells and their microenvironment can affect T cell metabolism, making metabolic modulation a promising approach to enhance CAR T cell therapy.

CANCERS (2022)

Letter Rheumatology

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells

Christina Bergmann, Fabian Mueller, Joerg H. W. Distler, Andrea-Hermina Gyoerfi, Simon Voelkl, Michael Aigner, Sascha Kretschmann, Hannah Reimann, Thomas Harrer, Nadine Bayerl, Sebastian Boeltz, Andreas Wirsching, Jule Taubmann, Wolf Roesler, Bernd Spriewald, Jochen Wacker, Armin Atzinger, Michael Uder, Torsten Kuwert, Andreas Mackensen, Georg Schett

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Hematology

Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCT

F. Karl, C. Liang, R. Boettcher-Loschinski, A. Stoll, C. Flamann, S. Richter, C. Lischer, S. Voelkl, B. Jacobs, M. Boettcher, R. Jitschin, H. Bruns, T. Fischer, E. Holler, W. Roesler, T. Dandekar, A. Mackensen, D. Mougiakakos

Summary: Allo-SCT is a curative treatment for hematologic malignancies, relying on the graft-versus-leukemia (GVL) effect of donor T cells. Oxidative stress caused by DNA damage weakens the function of T cells and hampers the GVL effect. High levels of 8-hydroxydeoxyguanosine (8-OHdG), a biomarker for oxidative stress, were associated with enhanced T-cell activation, premature exhaustion, increased relapse risk, and shorter overall survival. Enhancing DNA repair in reconstituting T cells could improve GVL efficacy.

BLOOD (2023)

Letter Medicine, General & Internal

CD19-targeted CAR T cells in refractory antisynthetase syndrome

Fabian Mueller, Sebastian Boeltz, Johannes Knitza, Michael Aigner, Simon Voelkl, Soraya Kharboutli, Hannah Reimann, Jule Taubmann, Sascha Kretschmann, Wolf Roesler, Bernhard Manger, Jochen Wacker, Dimitrios Mougiakakos, Samir Jabari, Rolf Schroeder, Michael Uder, Frank Roemer, Gerhard Kroenke, Andreas Mackensen, Georg Schett

LANCET (2023)

Article Oncology

Accumulation of T-cell-suppressive PD-L1high extracellular vesicles is associated with GvHD and might impact GvL efficacy

Rebecca Baur, Franziska Karl, Romy Boettcher-Loschinski, Andrej Stoll, Simon Voelkl, Andreas Giessl, Cindy Flamann, Heiko Bruns, Ursula Schloetzer-Schrehardt, Martin Boettcher, Denis M. Schewe, Thomas Fischer, Regina Jitschin, Andreas Mackensen, Dimitrios Mougiakakos

Summary: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment option for certain hematological malignancies. However, allo-HSCT can also lead to graft-versus-host disease (GvHD) and disease relapse. Recent studies have found that extracellular vesicles (EVs) expressing PD-L1 can suppress T-cell responses and contribute to GvHD and disease relapse in allo-HSCT patients.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Biology

Characterization and Quantitation of the Tumor Microenvironment of Uveal Melanoma

Lara Goesmann, Nasrin Refaian, Jacobus J. Bosch, Ludwig M. Heindl

Summary: This study aims to provide a detailed understanding of the tumor microenvironment of uveal melanoma (UM) to identify new therapeutic targets. The main findings are that blood vessels are predominantly located in the middle of the tumor, while immune cells are mainly found in the outer section. The high presence of LAG-3 and Galectine-3 in the UM serves as potential therapeutic targets.

BIOLOGY-BASEL (2023)

Article Public, Environmental & Occupational Health

Concordance of emergency department physicians' decisions on HIV post-exposure prophylaxis with national guidelines: results from a retrospective cohort study

Johannes Heck, Christoph Hoener zu Siederdissen, Olaf Krause, Sebastian Schroeder, Martin Schulze Westhoff, Patrick-Pascal Strunz, Carsten Schumacher, Dirk O. Stichtenoth, Jacobus J. Bosch, Thorben Pape, Felix Koop, Benjamin Krichevsky

Summary: ED physicians' decisions on HIV-PEP were highly consistent with national guidelines, and the proportion of patients seeking HIV-PEP in the emergency department was low. It is necessary to train ED physicians on HIV transmission risk assessment and indications/contraindications for HIV-PEP.

INTERNATIONAL HEALTH (2023)

Article Biology

How enhancers regulate wavelike gene expression patterns

Christine Mau, Heike Rudolf, Frederic Strobl, Benjamin Schmid, Timo Regensburger, Ralf Palmisano, Ernst H. K. Stelzer, Leila Taher, Ezzat El-Sherif

Summary: This article addresses the question of how genes are regulated in terms of timing and spatial pattern during development. By studying the AP patterning of the beetle Tribolium, the authors established a model system to investigate dynamic and temporal pattern formation at the enhancer level. They discovered dynamic enhancers and static enhancers that play a balancing role in regulating gene expression during embryonic pattern formation.

ELIFE (2023)

Article Multidisciplinary Sciences

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

Kai Rejeski, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L. Buecklein, Simon Voelkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Mueller, Philipp Karschnia, Agnese Petrera, Kayla Reid, Rawan Faramand, Marco L. Davila, Karnav Modi, Erin A. Dean, Christina Bachmeier, Michael von Bergwelt-Baildon, Frederick L. Locke, Wolfgang Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D. Jain, Marion Subklewe

Summary: Study reveals that intermittent neutrophil recovery after CAR-T cell therapy is associated with better survival outcomes, while aplastic recovery is associated with unfavorable expansion and tumor burden. Serum proteomics analysis shows that prolonged neutrophil aplasia occurs in patients with baseline systemic immune dysregulation, characterized by markers of endothelial dysfunction, increased inflammatory cytokines, macrophage activation, and T cell suppression. The association between neutrophil recovery and survival outcomes highlights critical interactions between host hematopoiesis and the immune state stimulated by CAR-T infusion.

SCIENCE ADVANCES (2023)

No Data Available